The purpose of this study is to examine the pharmacokinetic properties of Tapimycin injection
(piperacillin 4 g + tazobactam 0.5 g powder for injection) in healthy volunteers under
Drug: Tapimycin (piperacillin 4 g + tazobactam 0.5g)
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT00924742
Ages eligible for Study
20 Years to 40 Years
Genders eligible for Study
Accepts Healthy Volunteers
Provision of signed written informed consent before enrollment into the study, ability to communicate with the investigators, and to understand and comply with the requirements of the study.
Healthy adult male, aged between 20 and 40 years old.
Body Mass Index (BMI) between 18.5 and 25.
Physically and mentally healthy subjects as confirmed by an interview, medical history, clinical examination, chest x-ray and electrocardiogram.
No significant deviation from normal biochemistry.
No significant deviation from normal hematology.
No significant deviation from normal urinalysis.
History of drug or alcohol abuse within the past year.
Medical history of severe drug allergy or sensitivity to analogous drug.
Acute or chronic diseases or having undergone surgery from 4 weeks prior to PeriodI dosing.
Any clinical significant renal, cardiovascular, hepatic, hematopoietic, neurological, pulmonary or gastrointestinal pathology.
Ongoing peptic ulcer and constipation.
Planned vaccination during the time course of the study.
Taking any clinical study drug from 3 months prior to Period I dosing.
Use of any medication, including herb medicine or vitamins from 4 weeks before the study.
Blood donation of more than 500 mL within the past 3 months.
A positive Hepatitis B surface antigen or positive Hepatitis C antibody.
A positive test for HIV antibody.
All locations for NCT00924742
View full eligibility
Tris trial is registered with FDA with number: NCT00924742. The sponsor of the trial is Tri-Service General Hospital and it is looking for 12 volunteers for the current phase.
Official trial title: A Single-Dose Pharmacokinetics Study of Tapimycin Injection(Piperacillin 4 g + Tazobactam 0.5 g Powder for Injection) Administered Under Fasting Conditions to Healthy Adult Subjects
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Thank you for applying!
We'll contact you soon with more information.
FindMeCure is constantly improving its search. Take part in it and help millions by filling our patients' survey!